Search Results 1961-1970 of 110306 for b-
- WOCBP receiving nivolumab (Parts A+B) or nivolumab and ipilimumab (Part B) will be instructed to adhere to contraception for a period of 5 months after ...
Displaying 1-10 out of 20 doctors available. Last Name Initial: B,B. Gregory W. Barsness, M.D.. Interventional Cardiologist. Rochester ...
B: Border irregularity. Melanomas may have borders that are uneven or jagged. Those growths need to be seen by a healthcare professional. Melanoma with ...
... B, Vandenberg J, Mahajan B, Erben Y. Higher Risk for Morbidity and Non-Aortic Related Mortality in Type 2 Endoleak Patients Treated Outside of Instructions ...
BPPV causes brief periods of mild to intense dizziness. Certain changes in the head's position most often set them off. This might happen from tipping the head ...
... B, Deroose CM, Herrmann SM, Wells SL, Kaunfer SA, Ortega JL, Garcia-Carro C, Bold M, Chen KL, Sise ME, Heidari P, Pak WLW, Lee MD, Beckerman P, Eshet Y, Hsu ...
Last Name Initial: B,B,B,B. Research. Malignant glioma cells Enlarge image. Close. Malignant glioma cells ...
This medicine may cause a hepatitis B infection to worsen if you stop using it. Your doctor may check for the presence of hepatitis B before and during ...
Caitlin B. Conboy, M.D., Ph.D. 2019-2020. Leia Troop 2019. Summer Undergraduate Research Fellowship (SURF). Adiba I. Azad, M.D. 2018-2019. Tomohiro Katsumi ...
Show more areas of focus for Kristen B. McCullough, Pharm.D., R.Ph. Ivana N ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.